Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance

International Journal of Gynecological Cancer

Volumn 25, Issue 6, 2015, Pages 1086-1093

  Verbeek, Floris P R ^a   Tummers, Quirijn R J G ^a   Rietbergen, Daphne D D ^a   Peters, Alexander A W ^b   Schaafsma, Boudewijn E ^a   Van De Velde, Cornelis J H ^a   Frangioni, John V ^c   Van Leeuwen, Fijs W B ^a   Gaarenstroom, Katja N ^b   Vahrmeijer, Alexander L ^a  

^a MRI Facility   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Image guided surgery; Multimodal imaging; Near infrared fluorescence; Sentinel lymph node mapping; Vulvar cancer

Indexed keywords

INDOCYANINE GREEN; TECHNETIUM 99M; COLORING AGENT; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M NANOCOLLOID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BODY MASS; CANCER INFILTRATION; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IMAGING; GAMMA CAMERA; GOLD STANDARD; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN INCISION; TUMOR VOLUME; VERY ELDERLY; VULVA CANCER; DIAGNOSTIC IMAGING; FLUORESCENCE; FOLLOW UP; IMAGE GUIDED BIOPSY; MIDDLE AGED; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; SCINTISCANNING; TISSUE DISTRIBUTION; VULVA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; FEMALE; FLUORESCENCE; FOLLOW-UP STUDIES; HUMANS; IMAGE-GUIDED BIOPSY; INDOCYANINE GREEN; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; SPECTROSCOPY, NEAR-INFRARED; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TISSUE DISTRIBUTION; VULVAR NEOPLASMS;

EID: 84936932747     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000419     Document Type: Article

References (31)

1. Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the vulva. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006; 95(suppl 1): S7YS27.
2. Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995; 57: 327-334.
3. Hacker NF, Leuchter RS, Berek JS, et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981; 58: 574-579.
4. Gaarenstroom KN, Kenter GG, Trimbos JB, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003; 13: 522-527.
5. Rouzier R, Haddad B, Dubernard G, et al. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg. 2003; 196: 442-450.
6. De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002; 95: 2331-2338.
7. Hassanzade M, Attaran M, Treglia G, et al. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol. 2013; 130: 237-245.
8. Johann S, Klaeser B, Krause T, et al. Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer. Gynecol Oncol. 2008; 110: 324-328.
9. Hacker NF, Berek JS, Lagasse LD, et al. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol. 1983; 61: 408-412.
10. Makar AP, Scheistroen M, Van den Weyngaert D, et al. Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Reviewof literature. Int J Gynecol Cancer. 2001; 11: 255-262.
11. Van Der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008; 26: 884-889.
12. Erickson BK, Divine LM, Leath CA III, et al. Cost-effectiveness analysis of sentinel lymph node biopsy in the treatment of early-stage vulvar cancer. Int J Gynecol Cancer. 2014; 24: 1480-1485.
13. Radziszewski J, Kowalewska M, Jedrzejczak T, et al. The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma. Gynecol Oncol. 2010; 116: 473-477.
14. Schaafsma BE, Mieog JS, Hutteman M, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011; 104: 323-332.
15. Verbeek FP, Troyan SL, Mieog JS, et al. Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat. 2014; 143: 333-342.
16. Van Der Vorst JR, Hutteman M, Gaarenstroom KN, et al. Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients. Int J Gynecol Cancer. 2011; 21: 1472-1478.
17. Vahrmeijer AL, Hutteman M, Van Der Vorst JR, et al. Imageguided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013; 10: 507-518.
18. Crane LM, Themelis G, Arts HJ, et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol. 2011; 120: 291-295.
19. Hutteman M, Van Der Vorst JR, Gaarenstroom KN, et al. Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol. 2012; 206: 89.e1-89.e5.
20. Schaafsma BE, Verbeek FP, Peters AA, et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers. BJOG. 2013; 120: 758-764.
21. Matheron HM, Van den Berg NS, Brouwer OR, et al. Multimodal surgical guidance towards the sentinel node in vulvar cancer. Gynecol Oncol. 2013; 131: 720-725.
22. Van Leeuwen AC, Buckle T, Bendle G, et al. Tracer-cocktail injections for combined pre- and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model. J Biomed Opt. 2011; 16: 016004.
23. Brouwer OR, Buckle T, Vermeeren L, et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine greenY99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med. 2012; 53: 1034-1040.
24. Brouwer OR, Van den Berg NS, Matheron HM, et al. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye. Eur Urol. 2014; 65: 600-609.
25. Oonk MH, Van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of nonYsentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010; 11: 646-652.
26. Schaafsma BE, Verbeek FP, Rietbergen DD, et al. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg. 2013; 100: 1037-1044.
27. Mieog JS, Troyan SL, Hutteman M, et al. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol. 2011; 18: 2483-2491.
28. Troyan SL, Kianzad V, Gibbs-Strauss SL, et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol. 2009; 16: 2943-2952.
29. Nieweg OE, Tanis PJ, Kroon BB. The definition of a sentinel node. Ann Surg Oncol. 2001; 8: 538-541.
30. Van Der Poel HG, Buckle T, Brouwer OR, et al. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol. 2011; 60: 826-833.
31. Vahrmeijer AL, Frangioni JV. Seeing the invisible during surgery. Br J Surg. 2011; 98: 749-750.